ALIAmides |
Autacoid local injury antagonist amides |
BBB |
Blood–brain barrier |
BSCB |
Blood-spinal cord barrier |
CCI |
Chronic constriction injury |
CIPN |
Chemotherapy-induced peripheral neuropathy |
CNS |
Central nervous system |
DPN |
Diabetic painful neuropathy (DPN) |
GPR |
Receptor G-protein coupling |
IASP |
International Association for the Study of Pain |
MAPK |
Mitogen-activated protein kinase |
MC |
Mast cell |
m-PEA |
micronized-PEA |
NAAA |
N-acylethanolamine-hydrolyzing acid amidase |
NAEs |
N-acyl ethanolamines |
OEA |
Oleoyl ethanolamide |
PEA |
Palmitoyl ethanolamide |
PEA-OXA |
2-pentadecyl-2-oxazoline |
PGA |
N-Palmitoyl-d-glucosamine |
PNI |
Peripheral nerve injury |
PNS |
Peripheral nervous system |
PPAR-α |
Peroxisome proliferator-activated receptor-α |
ROS |
Reactive oxygen species |
SEA |
Stearoyl ethanolamide |
SNI |
Spared nerve injury |
SNRIs |
Serotonin-norepinephrine reuptake inhibitors |
STZ |
Streptozotocin |
TRPV1 |
Transient receptor potential vanilloid receptor type 1 |
TCAs |
Tricyclic antidepressants |
um-PEA |
Ultramicronized-PEA |